FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Clinical trial NCT04965753 · TERMINATED
Trial details
- NCT number
- NCT04965753
- Sponsor
- Foghorn Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-17
- Primary completion
- 2023-12-04
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.